It is a life sciences private limited company based in Hyderabad, Telangana, India, established in 2008.
2008 | Hyderabad, Telangana, India | ActiveDhanwantari Therapeutics Private Limited, a active private limited company, was established on 14 March 2008 in Hyderabad, Telangana, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U24100TG2008PTC058165. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kamalakara Sharma Pantangi (Director), Jayasree Sarma Pantangi (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 8-1-206/A, Raghavendra Hills, Mylardevpally Near Kattedan, Rajendranagar Mandal, Hyderabad, Telangana, 500005.
U24100TG2008PTC058165
058165
14 March 2008
₹2.50 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Dhanwantari Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamalakara Sharma Pantangi | Director | 14 Mar 2008 | Current |
| Jayasree Sarma Pantangi | Director | 14 Mar 2008 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dhanwantari Therapeutics Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.27% increase. The company also saw a slight improvement in profitability, with a 3.22% increase in profit. The company's net worth Soared by an impressive increase of 12.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Dhanwantari Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dhanwantari Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dhanwantari Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanwantari Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dhanwantari Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Dhanwantari Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was completed.
The activity Kamalakara Sharma Pantangi was appointed as a Director was appointed as a Director on 14 Mar 2008 & has been associated with this company since 17 years 8 months . was completed.
The activity Jayasree Sarma Pantangi was appointed as a Director was appointed as a Director on 14 Mar 2008 & has been associated with this company since 17 years 8 months . was completed.
The activity Dhanwantari Therapeutics Private Limited was registered on 14 Mar 2008 with Roc Hyderabad & aged 17 years 8 months as per MCA records. was completed.
The CIN of Dhanwantari Therapeutics Private Limited is U24100TG2008PTC058165.
Dhanwantari Therapeutics Private Limited is headquartered at 8-1-206/A, Raghavendra Hills, Mylardevpally Near Kattedan, Rajendranagar Mandal, Hyderabad, Telangana, 500005.
Dhanwantari Therapeutics Private Limited was incorporated on 14 March 2008.
The current directors of Dhanwantari Therapeutics Private Limited are
The primary industry of Dhanwantari Therapeutics Private Limited is Life Sciences.
Dhanwantari Therapeutics Private Limited is unlisted.
The authorized capital of Dhanwantari Therapeutics Private Limited is ₹2.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dhanwantari Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX